US Pre-Market SEC Filings Roundup — March 30, 2026

30-03-2026

General Enterprise Ventures, Inc. reported revenue of $2,381,407 for the year ended December 31, 2025, marking a 195% increase from $808,372 in 2024. However, operating expenses surged 209% to $18,877,398, other expenses skyrocketed 1,190% to $20,341,652, and the net loss widened dramatically by 435% to $36,837,643 from $6,881,722. The company highlighted ongoing risks including high leverage, stock volatility, dilution from share issuances, and challenges in achieving profitability.

• ·Recent sales of unregistered securities included 220,000 shares for IP acquisition valued at $1,775,400 from Breakthrough Chemistry, Inc.
• ·346,127 shares issued via cashless conversion of 359,375 warrants.
• ·500,000 shares issued upon conversion of 150,000 shares of Series C Convertible Preferred Stock.
• ·475,862 shares issued for conversion of $1,071,821 in debt and accrued interest.
• ·55,333 shares issued for services valued at $443,377.

30-03-2026

Soluna Holdings, Inc. filed an S-3/A amendment to its shelf registration statement (No. 333-294152) on March 30, 2026, registering securities including preferred stock, warrants, debt indentures, notes, and units. The filing primarily lists exhibits incorporated by reference from prior SEC reports, such as various certificates of amendment and designations for Series A and Series B preferred stock. It is signed by CEO John Belizaire and other executives and directors in Albany, New York, with no financial performance data or period comparisons disclosed.

• ·Registration No. 333-294152
• ·References prior filings including 2020 Form 10-K and multiple 8-Ks up to November 10, 2025
• ·Exhibits marked * filed herewith, ** previously filed, *** or † to be filed by amendment

30-03-2026

News Corporation disclosed updates to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program authorizing purchases of Class A (NWSA) and Class B (NWS) common stock, with information attached as Exhibits 99.1 and 99.2. The filing notes daily ASX disclosure requirements for any transactions under the program and includes forward-looking statements about potential repurchases subject to market conditions.

• ·Filing date: March 30, 2026; Earliest event date: March 27, 2026
• ·Securities: Class A Common Stock (NWSA, par value $0.01), Class B Common Stock (NWS, par value $0.01), both on Nasdaq Global Select Market

30-03-2026

Alumis Inc. issued a press release announcing early and robust improvements in skin clearance, quality of life, and psoriasis symptoms from two Phase 3 trials of envudeucitinib, underscoring its potential as a leading oral therapy for plaque psoriasis. The company presented slides on these results at a late-breaking oral presentation at the 2026 American Academy of Dermatology Annual Meeting on March 28, 2026. No negative or flat performance metrics were reported.

• ·Plans to submit NDA for envudeucitinib in the second half of 2026.
• ·Expected availability of one-year Phase 3 long-term data in the second half of 2026.
• ·Development of once-daily formulation and pediatric development plan for envudeucitinib ongoing.

30-03-2026

ConocoPhillips filed DEFA14A additional proxy materials for its 2026 Annual Meeting of Stockholders on May 12, 2026, at 9:00 a.m. Central Time via virtual webcast. Key proposals include election of 13 director nominees, ratification of Ernst & Young LLP as independent auditors for 2026, and advisory approval of executive compensation (Board recommends FOR all), alongside a stockholder proposal for an independent board chairman (Board recommends AGAINST). The record date is March 18, 2026, with voting available online via ProxyVote.com until deadlines varying by plan (e.g., May 11, 2026).

• ·Record date for shareholders: March 18, 2026
• ·Virtual meeting URL: www.virtualshareholdermeeting.com/COP2026
• ·Proxy materials available online or by request before April 28, 2026
• ·Board discretion on other matters at the meeting

30-03-2026

Accelerant Holdings issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Meeting of Shareholders, scheduled for May 12, 2026, at 10:00 A.M. British Summer Time in a hybrid format (physical at London Marriott Grosvenor Square, London, and virtual webinar). Shareholders will vote on electing three Class I directors—Karen Meriwether, Simon Wainwright, and David Talach—for three-year terms expiring in 2029, and ratifying PricewaterhouseCoopers LLP as independent auditor for the year ending December 31, 2026. The Board recommends voting 'FOR' both proposals; proxy materials are available online at https://web.viewproxy.com/ARX/2026, with paper copies requestable by May 7, 2026.

• ·Voting methods: Internet at www.AALvote.com/ARX prior to or during the meeting using 11-digit Virtual Control Number.
• ·Physical meeting location: London Marriott Grosvenor Square, Grosvenor Sq, London W1K 6JP, United Kingdom.
• ·Virtual attendance requires pre-registration at https://web.viewproxy.com/arx/2026.

30-03-2026

HyOrc Corp's 10-K filing discloses a retained earnings deficit of $8,174,862, impairment loss of $300,000, credit loss of $95,747, and net cash used in operating activities of $336,057, reflecting ongoing cash burn and no revenue from its key joint venture. The company is developing an 8 TPD waste-to-methanol pilot facility in Portugal with Start Lda, not yet operational and expected no earlier than July 2026, with plans to expand to 80 TPD subject to financing and risks. Market capitalization stands at $62.3 million based on 737 million outstanding shares trading at $0.0845 per share, with no dividends expected.

• ·Phase 1 pilot facility not operational until July 2026 or later due to permitting, equipment, financing risks
• ·No binding off-take agreements in place for the project
• ·Company not generating revenue under Joint Venture Agreement with Start Lda
• ·No dividends paid historically and none expected
• ·Common stock quoted on OTCQB under ticker HYOR

30-03-2026

Perimeter Acquisition Corp. I (PMTRW), a blank check company with no operating history or revenues, filed its 10-K on March 30, 2026, disclosing sponsor compensation including 5,911,500 founder shares for $24,460 and 638,000 private placement units, alongside up to $1,500,000 in convertible working capital loans at $10.00 per unit that could cause significant dilution. The filing details 180-day transfer restrictions on founder shares post-IPO or business combination, uncapped reimbursement for sponsor out-of-pocket expenses, and redemption mechanics at approximately $10.00 per share in case of business combination or failure within 24 months of IPO closing. No initial business combination has been completed.

• ·Transfer restrictions on founder shares apply until 180 days after initial business combination or subsequent liquidation/merger/share exchange.
• ·Must complete initial business combination within 24 months from IPO closing or redeem public shares.
• ·No cap on reimbursement of out-of-pocket expenses for sponsor, officers, directors, or affiliates related to business combination activities.
• ·Private placement warrants are non-redeemable.

30-03-2026

Picard Medical, Inc. reported total net revenues of $4,940 thousand for the year ended December 31, 2025, up 13% YoY from $4,391 thousand, with products revenue increasing 12% to $4,746 thousand and rentals surging 42% to $194 thousand. However, gross loss widened 82% to $(204) thousand due to a 38% rise in product costs to $3,432 thousand despite a 15% decline in rental costs, while net loss grew 28% to $(27,002) thousand driven by 86% higher other expenses including derivative losses up 64% and interest expense up 76%. Operating expenses declined slightly 4% to $13,053 thousand with R&D down 10% and SG&A flat at -2%, and cash balances improved to $7,451 thousand from $96 thousand bolstered by financing activities.

• ·Auditors included explanatory paragraph on going concern due to ability to continue as a going concern.
• ·Cash used in operating activities increased to $15,673 thousand from $11,874 thousand.
• ·No cash used in investing activities in either year.
• ·Total current liabilities decreased to $18,695 thousand from $35,325 thousand.
• ·Preferred stock converted to common stock; no Series A-1 outstanding as of Dec 31 2025.
• ·Stock-based compensation expense $754 thousand in 2025.

30-03-2026

RYVYL Inc. reported that RTB Digital, Inc., its proposed merger partner (with Ryvyl as surviving entity), entered a confidential Strategic Partnerships and Investment Terms Agreement to acquire a controlling interest in a strategically aligned company, including a $10 million non-refundable deposit applied to the final purchase price. Upon merger consummation, Ryvyl will assume the agreement through its wholly owned subsidiary RTB. Negotiations on certain terms continue, expected to resolve within 30 days, subject to conditions like funding, additional purchase price payment, and assumption of seller debt.

• ·Date of earliest event: March 25, 2026
• ·Filing date: March 30, 2026
• ·Substantive conditions for Strategic Agreement consummation include funding, payment of additional purchase price, and RTB assuming a portion of seller group outstanding debt

30-03-2026

Our Bond, Inc. (OBAI) entered into Amendment No. 2 to its Securities Purchase Agreement (Equity Line SPA) with Ascent Partners Fund LLC on March 29, 2026, amending terms for Regular Closings (max $1,000,000 or 100% of average daily traded value over prior 10 trading days) and Expanded Closings (up to $5,000,000 under specific volume and price conditions or if average daily traded value exceeds $4,000,000). The amendment allows advance notices anytime during trading days, multiple per day, and includes extended hours trading in key definitions. No financial performance metrics or period comparisons are reported.

• ·Expanded Closing advance notice requires trading volume exceeding 3 times the average daily volume over the prior 10 trading days.
• ·VWAP, daily traded value, and volume definitions now include extended hours trading.
• ·Equity Line SPA effective date clarified as the registration statement effective date for Ascent’s resale of shares.

30-03-2026

OnKure Therapeutics entered into a securities purchase agreement on March 27, 2026, for a private placement expected to generate approximately $150.0 million in gross proceeds through the sale of 26,713,636 shares of Class A common stock at $4.15 per share and pre-funded warrants to purchase 9,430,959 shares at $4.1499 per underlying share, with closing anticipated on March 31, 2026. The company elected Dr. Liam Ratcliffe, affiliated with lead investor AI Biotechnology LLC, as a Class I director effective upon closing, and plans to use proceeds for preclinical/clinical development of next-generation PI3Kα inhibitors OKI-345 and OKI-355, with IND submissions targeted for H1 2027. However, despite progress in the PIKture-01 trial (completed dose escalations with n=38 single-agent and n=33 + fulvestrant), the company will not pursue further independent clinical development of OKI-219.

• ·Private Placement closing subject to customary conditions on March 31, 2026.
• ·180-day lock-up for executives/directors and Company on share issuances post-Closing.
• ·Registration Statement to be filed within 30 days after Closing, with effectiveness targets of 90-120 days.
• ·Pre-Funded Warrants exercisable at $0.0001 per share, no expiration until fully exercised.
• ·Phase 2 dose evaluation in PIKture-01 (OKI-219 triplets) to complete in 2026; mature data presentation by year-end.
• ·Dr. Ratcliffe to receive standard non-employee director compensation per Company policy.

30-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 30, 2026, under Item 8.01 to furnish a press release titled 'AITX's RAD Reports Its Strongest ISC West Showing to Date,' attached as Exhibit 99.1. The filing notes that the information is furnished and not deemed filed for liability purposes. No financial metrics or period comparisons are disclosed.

• ·Filing Type: 8-K (Items 8.01, 9.01)
• ·Date of Report: March 30, 2026
• ·Registrant State: Nevada; CIK: 0001498148; EIN: 27-2343603
• ·Principal Address: 10800 Galaxie Avenue, Ferndale, Michigan 48220

30-03-2026

Amphenol Corporation entered into an Indenture dated March 30, 2026, with Amphenol Technologies Holding GmbH as issuer, Amphenol Corporation as guarantor, and U.S. Bank Trust Company, National Association as trustee, for the issuance of Notes. This agreement creates a direct financial obligation under Item 2.03. The filing incorporates an Officers’ Certificate establishing the Notes and lists various exhibits including legal opinions.

• ·Exhibits include: 4.1 (Indenture), 4.2 (Officers’ Certificate), 4.3 (Form of Global Note), 5.1 (Opinion of Latham & Watkins LLP, New York), 5.2 (Opinion of Latham & Watkins LLP, Frankfurt), 23.1 and 23.2 (Consents), 104 (XBRL Cover Page)
• ·Incorporated by reference into Registration Statement No. 333-293923

30-03-2026

On March 27, 2026, Dyadic International, Inc. received a Nasdaq deficiency notice for failing to comply with Continued Listing Rule 5550(b), requiring at least $2.5 million in stockholders’ equity, $35 million in market value of listed securities, or $500,000 in net income from continuing operations; the notice has no immediate listing effect but mandates a compliance plan by May 11, 2026, with potential extension to September 23, 2026. The company plans to pursue compliance, likely via the equity threshold, amid ongoing non-compliance with the $1.00 minimum bid price rule (deadline June 17, 2026), either of which could lead to delisting if unresolved.

• ·The deficiency notice has no immediate effect on the listing of DYAI common stock on Nasdaq Capital Market.
• ·Company remains out of compliance with separate minimum bid price requirement, which is unrelated to the new notice.

30-03-2026

A Paradise Acquisition Corp. is pursuing a business combination with Enhanced Ltd., the company behind the Enhanced Games, which has launched an online personalized performance medicine platform offering proprietary supplements, hormone therapy, and peptides like Sermorelin, with plans to expand to seven more if FDA regulations ease on 14 Category 2 peptides. The global peptide therapeutics market is estimated at $52B today, potentially reaching $87B by 2035, with $15B in the US portion of an $80B market, presenting significant opportunities. However, Enhanced has an unproven business model, limited operating history, and minimal revenue to date, alongside regulatory, ethical, and competitive risks.

• ·Inaugural Enhanced Games event scheduled for May 24, 2026 in Las Vegas
• ·Platform launched less than a month ago with positive early DTC metrics (volume, visits, average order size, cart adds) on small numbers
• ·Form S-4 registration statement filed with SEC, including proxy statement/prospectus

30-03-2026

Origin Materials reported total revenues of $18,922 thousand for 2025, down 40% YoY from $31,282 thousand, primarily due to lower product sales, while services revenue dropped to zero from $3 thousand. A massive $195,636 thousand asset impairment drove operating expenses up 204% to $259,634 thousand and net loss to $(249,698) thousand, worsening 198% from $(83,697) thousand; however, Adjusted EBITDA improved to $(43,368) thousand from $(48,367) thousand, and net cash used in operations decreased to $(32,793) thousand from $(50,830) thousand. Total assets shrank to $157,660 thousand from $378,027 thousand, with cash and equivalents at $32,923 thousand.

• ·Stock-based compensation decreased to $8,914 thousand from $10,080 thousand.
• ·Net cash provided by financing activities increased to $10,659 thousand, driven by $15,000 thousand proceeds from convertible notes.
• ·Common stock warrants liability decreased to $167 thousand from $4,566 thousand.

30-03-2026

Aldabra 4 Liquidity Opportunity Vehicle, Inc. (ALOV), a blank check company incepted on July 24, 2025, reported total assets of $285,064, including $23,583 in cash and $261,481 in deferred offering costs, as of December 31, 2025. Total liabilities stood at $338,146, resulting in a shareholder’s deficit of $53,082, with a net loss of $78,082 for the period from inception through December 31, 2025, driven entirely by formation and general administrative expenses and no revenue.

• ·Accounts payable: $11,246 as of December 31, 2025
• ·Accrued expenses: $13,125 as of December 31, 2025
• ·Accrued offering costs: $113,775 as of December 31, 2025
• ·Basic and diluted net loss per Class B ordinary share: ($0.01)
• ·Class B ordinary shares authorized: 20,000,000

30-03-2026

Remora Capital Corp's 10-K annual report filing highlights its pursuit of regulated investment company (RIC) status under subchapter M of the Internal Revenue Code and business development company (BDC) status under the 1940 Act, including asset composition requirements such as at least 50% in cash equivalents and limited issuer exposures. It references small company thresholds of total assets not exceeding $4 million and capital/surplus of at least $2 million, alongside a gross revenue trigger of $1.235 billion. Risks disclosed include corporate debt market declines reducing portfolio NAV, global economic uncertainties affecting operations, and mandatory debt prepayments limiting portfolio company flexibility.

• ·RIC asset test limits: other securities of any one issuer not more than 5% of assets or 10% of voting securities.
• ·Risk of increased net unrealized depreciation from price declines and illiquidity in corporate debt markets.

30-03-2026

JENA ACQUISITION Corp II, a blank check company with no operating history or revenues, reported total assets of $236,574,719 as of December 31, 2025, driven by $235,449,992 in the Trust Account from 23,000,000 Class A Ordinary Shares at $10.24 per share. For the period from inception (February 24, 2025) to December 31, 2025, it recorded a net loss of $1,836,775 on a $7,286,767 operating loss from formation costs ($386,767) and advisory fees ($6,900,000), partially offset by $5,449,992 in Trust Account interest income, resulting in a shareholders' deficit of $12,700,299. No business combination has been completed, limiting evaluation of future prospects.

• ·Basic and diluted net loss per share of $0.08 for both Class A and Class B Ordinary Shares.
• ·Risks include potential negative interest rates on Trust Account investments, post-combination foreign asset/revenue concentration, and limited shareholder basis for evaluation due to no revenues or operations.

30-03-2026

On March 23, 2026, Oncotelic Therapeutics, Inc. announced that Sapu Nano, in which the Company holds a minority interest, will present new data on evorlimus toxicology at the Society of Toxicology (SOT) 2026 Annual Meeting and ToxExpo in San Diego, California. The press release is attached as Exhibit 99.1 and the poster presentation as Exhibit 99.3. No financial impacts or performance metrics were disclosed.

• ·Event reported date: March 23, 2026
• ·Filing signed: March 27, 2026
• ·Location: San Diego, California

30-03-2026

HCM IV Acquisition Corp., a blank check company and shell entity, reported total assets of $160,959, primarily consisting of $25,000 in prepaid expenses and $135,959 in deferred offering costs as of December 31, 2025. The company recorded a net loss of $59,655 from formation and administrative costs for the period from inception (September 5, 2025) through December 31, 2025, resulting in total liabilities of $195,614 (including a $154,819 related party promissory note) and a shareholders' deficit of $34,655, with zero cash on hand at period end.

• ·Entity is a shell company (true), emerging growth company (true), small business (true), and non-accelerated filer.
• ·Entity Central Index Key: 0002089982; Entity Tax ID: 98-1883478.
• ·Address: 85 Washington St, 1F, Stamford, CT 06854; Phone: (203) 930-2200.
• ·Securities listed on NASDAQ.
• ·Basic and diluted net loss per Class B share: $(0.01).
• ·Net cash used in operating activities: $0.

30-03-2026

Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported in its 10-K that it has never generated product revenues, anticipates significant ongoing losses, and has substantial doubt about its ability to continue as a going concern due to the need for substantial additional capital. The company is heavily dependent on brilaroxazine, its sole advanced product candidate still in clinical development, with no offsetting positive financial metrics or achievements noted. Risks include material weaknesses in internal controls over financial reporting as of December 31, 2025, potential Nasdaq delisting, reliance on third parties for trials and manufacturing, and significant competition.

• ·Certain warrants are accounted for as liabilities, with changes in value potentially having a material effect on financial results.
• ·No current intention to pay dividends on common stock in the foreseeable future.

30-03-2026

Osisko Development Corp. filed its Form 40-F Annual Report on March 30, 2026. The filing lists the company's Common Shares (no par value, trading symbol ODV) registered on the New York Stock Exchange and Warrants (exercisable for one Common Share at $10.70, trading symbol ODVWZ) on The Nasdaq Stock Market LLC.

30-03-2026

HCM III Acquisition Corp., a SPAC, reported net income of $2,192,991 for the period from inception (April 15, 2025) through December 31, 2025, driven by $4,298,929 in interest from the Trust Account holding $257,298,929 (25,300,000 Class A shares at $10.17 redemption value). However, the company raised substantial doubt about its ability to continue as a going concern due to only $1,015,282 in cash, operating losses of $914,236, and a shareholders' deficit of $12,787,848, potentially requiring additional funding from its Sponsor amid risks of liquidation if no business combination is completed.

• ·Basic and diluted net income per ordinary share: $0.10 for both Class A and Class B shares.
• ·Over-allotment option exercised in full by underwriters on August 4, 2025.
• ·Net cash used in operating activities: $355,263.
• ·Non-cash deferred underwriting fee payable: $12,045,000.

30-03-2026

707 Cayman Holdings Ltd., a Cayman Islands exempted company listed on Nasdaq Capital Market since June 9, 2025, filed an F-1 registration statement on March 27, 2026, to register securities with the SEC. The filing discloses significant risks including limited shareholder rights and enforcement challenges under Cayman Islands law, reduced reporting as an emerging growth company and foreign private issuer, increased compliance costs from public listing, and regulatory scrutiny on emerging market companies (e.g., China/Hong Kong) related to PCAOB audit inspections under HFCA Act and AHFCAA, potentially leading to delisting.

• ·Nasdaq listing date: June 9, 2025
• ·Annual report on Form 20-F due within four months of fiscal year-end
• ·Semi-annual financial results via press releases furnished on Form 6-K
• ·SEC/PCAOB joint statements: December 7, 2018; April 21, 2020
• ·HFCA Act: U.S. Senate May 20, 2020; House December 2, 2020
• ·Nasdaq proposals filed: May 21, 2021
• ·Senate AHFCAA passage: June 22, 2021

30-03-2026

Presidio Property Trust reported a reduced net loss of $10.5 million ($8.59 per share) for the year ended December 31, 2025, improved from $27.9 million ($22.50 per share) in 2024, driven by gains from commercial property sales ($15.9 million, $4.5 million gain) and lower G&A expenses (down 24.2%). However, total revenue declined 11.2% to $16.8 million from $18.9 million due to commercial property sales, with a $6.4 million impairment charge and worsening FFO to $(3.8) million from $(3.4) million. Model home segment showed strength with 88% tenant renewal and acquisitions of 22 properties for $9.4 million, though average homes held dropped to 79 from 94.

• ·Office/Industrial segment NOI $5.8M; Model Homes adjusted NOI $4.4M for 2025.
• ·Series D Preferred Stock dividends flat at $2.34372 per share for both 2025 and 2024.
• ·Subsequent events: Dakota Center sold Jan 14 2026 for $5.125M; five model homes sold Feb-Mar 2026 for $2.5M with $0.1M gain.
• ·Weighted average interest rate increased to 6.16% from 5.63% YoY.

30-03-2026

Gores Holdings X, Inc., a SPAC, completed its IPO in 2025, raising $358,800,000 in proceeds and funding the Trust Account to $367,742,183, with net income of $920,659 driven by $9,511,647 in interest income. However, the company reported an operational net loss of $1,850,155, a $6,637,800 expense from change in fair value of public warrant liabilities, and basic/diluted net loss per share of $(0.76) across all classes due to accretion of temporary equity, resulting in shareholders' deficit widening to $(31,301,532) from $(40,000). Total assets grew significantly to $368,717,492 from $1,184,632, while cash ended at $619,576.

• ·IPO underwriter's discounts and commissions payment: $250,000
• ·Public warrants derivative liability: $8,162,700 as of Dec 31, 2025
• ·Initial classification of warrant liability - public (non-cash): $1,524,900
• ·Notes payable - related party repaid: $231,901 (after $59,000 proceeds)

30-03-2026

Cottonwood Communities, Inc. (CROP) reported NAV of $1,013,012 as of December 31, 2025, reflecting a decline in NAV per share to $11.3574 from $12.0083 at year-end 2024 (-5.4% YoY), though a valuation guideline change added approximately $19.42 million ($0.32 per share). Total revenues fell 2.9% YoY to $153,934 from $158,483, with rental revenues down 4.8% to $138,787, but Core FFO rose sharply 266% to $15,932 from $4,348, and net loss attributable to controlling interests improved to $(4,844) from $(10,956). The company repurchased 1,374,067 shares in Q4 2025 at an average price of about $11.29 per share.

• ·FFO per common share and unit - diluted: $(0.23) in 2025 vs $(0.01) in 2024.
• ·Core FFO per common share and unit - diluted: $0.22 in 2025 (up from $0.07).
• ·Stockholders’ equity: 282,807 as of Dec 31, 2025.
• ·Weighted-average diluted common shares and units: 71,259,649 in 2025 (up from 66,472,501).

30-03-2026

Endeavour Silver Corp (EXK) filed its 40-F Annual Report for the year ended December 31, 2025, including audited consolidated financial statements by KPMG LLP for 2025 and 2024, MD&A, and Annual Information Form. Audit fees increased 64.8% YoY to $1,910,726 from $1,159,465, while tax fees and all other fees remained flat at $0 for both years.

• ·Financial statements cover years ended December 31, 2025 and 2024.
• ·Auditor: KPMG LLP (Vancouver, BC, Canada; Auditor Firm ID: 85).
• ·Filing includes Inline XBRL documents (Exhibits 101.INS through 101.PRE).

30-03-2026

Volato Group, Inc. entered into an ATM Sales Agreement with Curvature Securities, LLC to offer and sell up to $3,700,000 of Class A Common Stock at-the-market. The company provided an update on its pending merger with M2i Global, Inc., where M2i shareholders are expected to receive approximately 85% ownership of the combined company (via ~119.2M shares), resulting in significant dilution for existing Volato shareholders who will hold ~15%. The merger faces risks including stockholder approvals, integration challenges, operational disruptions, and potential failure to realize strategic benefits.

• ·ATM sales made via methods permitted under Rule 415, including directly on NYSE American LLC.
• ·Merger Agreement originally dated July 28, 2025; shelf registration on Form S-3 (File No. 333-290219) effective September 30, 2025.
• ·Company plans to seek stockholder approval for potential reverse stock split to meet NYSE American listing requirements.
• ·Merger closing subject to M2i Global and Volato stockholder approvals, with risks of delays, termination, or adverse business impacts.

30-03-2026

Nexstar Media Group, Inc. and Nexstar Media Inc. entered into Amendment No. 9 to their Credit Agreement dated March 25, 2026, effective on the same date, under which Bank of America, N.A., as Term B-7 Lender, provides new Term B-7 Loans in an aggregate principal amount of $1,750,000,000. The proceeds are used to fully repay outstanding Term B-6 Loans (Term B-6 Refinancing) and pay fees and expenses associated with the transaction. The amendment includes standard conditions precedent, representations, and reaffirmations of loan documents, with no reported changes in financial performance metrics.

• ·Amendment executed by Borrower (Nexstar Media Inc.), Nexstar Media Group, Inc., other Loan Parties, Administrative Agent (Bank of America, N.A.), and Term B-7 Lender.
• ·Ninth Amendment Effective Date: March 25, 2026.
• ·SEC 8-K filing date: March 30, 2026, covering Items 1.01, 1.02, 2.03, 9.01.

30-03-2026

Contango ORE, Inc. (CTGO) filed an S-3 registration statement on March 30, 2026, to register up to 1,597,301 shares of common stock issuable upon exchange, retraction, or redemption of an equivalent number of Exchangeable Shares issued to eligible Canadian shareholders of Dolly Varden Silver Corporation as part of the acquisition arrangement. The prospectus details the company's exploration and development assets, including its 30% interest in the Peak Gold JV operating the Manh Choh Project, various Alaska properties totaling hundreds of thousands of acres, and the acquired Kitsault Valley Project in British Columbia spanning 100,000 hectares. No cash proceeds will be received, and extensive risk factors are highlighted, including operational, financial, and acquisition-related uncertainties.

• ·Peak Gold JV: CORE Alaska 30% interest, KG Mining 70% managing interest operating Manh Choh mines.
• ·Exchangeable Shares rights governed by Exchangeable Share Support Agreement and Voting and Exchange Trust Agreement, filed March 27, 2026.
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed March 16, 2026, incorporated by reference.
• ·Principal offices: 516 2nd Avenue, Suite 401, Fairbanks, Alaska 99701.
• ·NYSE American symbol: CTGO.

30-03-2026

The 21Shares Solana ETF (TSOL), launched on September 17, 2025, reported net assets of $5,735,019 as of December 31, 2025, with 460,000 shares outstanding at a NAV of $12.47 per share, down from higher inflows amid Solana holdings valued at $5,770,226 (cost basis $6,518,230). It generated $203,951 in staking fee income and $176,055 net investment income, but suffered a net realized and unrealized loss of $4,323,701, primarily from $3,578,079 realized loss on Solana sales and $748,004 unrealized depreciation, leading to a $4,147,646 net decrease from operations. Gross contributions totaled $119,956,526 while redemptions were $110,073,861, reflecting high turnover.

• ·Paid-in-capital: $9,882,665
• ·Staking fee payable: $19,187; Sponsor fee payable: $8,334; Block rewards payable: $7,686
• ·Solana purchased: 852,012.1255 quantity for $119,952,208
• ·Solana sold for redemptions: (807,060.9488) quantity for ($110,069,543)

30-03-2026

SmartStop Self Storage REIT, Inc. filed an 8-K on March 30, 2026, under Items 7.01 and 9.01, furnishing investor presentation materials as Exhibit 99.1 for use in investor communications pursuant to Regulation FD. The materials are deemed furnished and not filed, avoiding liabilities under Section 18 of the Exchange Act. The report was signed by James R. Barry, Chief Financial Officer and Treasurer.

• ·Securities: Common Stock, $0.001 par value, trading symbol SMA on New York Stock Exchange
• ·Principal executive offices: 10 Terrace Road, Ladera Ranch, California 92694
• ·Telephone: (866) 418-5144

30-03-2026

AB Private Credit Investors Corp and multiple affiliated Borrowers and General Partners entered into the Eighteenth Amendment to their Revolving Credit Agreement originally dated June 14, 2019, with HSBC Bank USA, National Association as Administrative Agent, effective as of March 23, 2026. The amendment modifies certain sections and schedules of the Credit Agreement as set forth in Annex A (not provided), subject to conditions including execution, beneficial ownership certifications, and payment of fees. All parties reaffirmed the validity of liens, resolutions, and obligations under the Loan Documents, with representations that no Potential Default or Event of Default exists.

• ·Original Revolving Credit Agreement dated June 14, 2019.
• ·This is the eighteenth amendment; prior amendments listed from December 23, 2020 through December 8, 2025.
• ·Governing law: State of New York.
• ·SEC Filing Date: March 30, 2026; Items: 1.01, 2.03, 9.01.

30-03-2026

Embraer S.A. reported FY2025 revenue of $7,577.5 million, up 18.5% YoY from $6,394.7 million, fueled by robust growth in Executive Aviation (+25.1% to $2,205.1M), Defense & Security (+36.5% to $983.9M), and Services & Support (+17.7% to $1,925.6M), while Commercial Aviation grew modestly (+7.3% to $2,369.8M). However, gross margin slipped to 17.5% from 18.0%, operating income declined 9.0% to $607.6 million amid higher expenses, and pre-tax income fell sharply to $267.6 million from $557.0 million due to elevated financial expenses. Net income edged up 1.2% to $359.0 million, with cash from operations stable at $870.0 million.

• ·Period-end exchange rate US$1.00 = R$5.5024 as of Dec 31, 2025
• ·Average exchange rate US$1.00 = R$5.5852 for FY2025
• ·Financial expenses increased to $615.0M in FY2025 from $415.6M in FY2024
• ·Total long-term debt maturities: $395.9M due 2030, $1,937.9M due 2031 and thereafter

30-03-2026

Electra Battery Materials Corp's 20-F Annual Report for the year ended December 31, 2025, shows significant improvements in liquidity risk, with short-term liabilities (<1 year) decreasing 44% to $6,623 from $11,797 in 2024, primarily due to the absence of convertible notes payable. Medium-term (1-2 years) liabilities dropped over 99% to $79 from $9,755, and long-term (>2 years) liabilities declined 59% to $44,045 from $107,633. Foreign currency net USD exposure also improved markedly, reducing to -$16,128 CAD from -$65,132 CAD, driven by higher cash balances and lower debt.

• ·2025 short-term liabilities include accounts payable and accrued liabilities of $5,817 and deferred government grant of $642.
• ·Convertible notes payable of $8,057 (<1 year), $8,012 (1-2 years), and $99,071 (>2 years) present in 2024 liquidity table but absent in 2025.
• ·2025 USD-denominated cash and cash equivalents rose to $25,019 (CAD) from $3,391 (CAD) in 2024.

30-03-2026

CIM Real Estate Finance Trust's total investment portfolio slightly declined 1.6% YoY to $4,686,426 across 294 assets from $4,764,899 across 276 assets, with loans held-for-investment net increasing to $3,454,589 (73.8%) but real estate-related securities net dropping sharply to $169,206 (3.5%) from $345,828 (7.3%). The company achieved a significant turnaround to net income attributable to the Company of $52,356 from a loss of $292,301, supported by lower expenses and real estate NOI growth of 13.9% to $98,940, though total revenues fell 14.0% to $416,004 and distributions decreased to $152,510 from $196,675.

• ·Credit segment revenues declined $85,667 YoY to $304,321.
• ·Current expected credit losses on loans improved to $(297,878) from $(392,136).
• ·Unused borrowing capacity decreased to $52,776 from $91,786.
• ·Weighted-average interest rate for CRE loans: 7.0%; Corporate senior loans: 9.5%.
• ·Same store rental income grew minimally by $421 to $86,333.

30-03-2026

RG&E Storm Funding, LLC, a bankruptcy-remote subsidiary of Rochester Gas and Electric Corporation, filed its annual 10-K for the fiscal year ended December 31, 2025, omitting most sections per General Instruction J for asset-backed securities issuers. The filing confirms no material instances of noncompliance with servicing criteria by the servicer (Rochester Gas and Electric Corporation) or indenture trustee (U.S. Bank Trust Company, National Association). It discloses ongoing litigations involving U.S. Bank as trustee in unrelated RMBS and student loan trusts, though U.S. Bank denies liability and asserts meritorious defenses.

• ·Managers and executive officers listed as of March 27, 2026: Michael Panichi (age 39), Andrea VanLuling (age 43), Michelle A. Dreyer (age 53).
• ·Key agreements dated February 14, 2025: Indenture, Series Supplement, Recovery Property Servicing Agreement, Recovery Property Purchase and Sale Agreement, Administrative Agreement.
• ·Auditor: KPMG, LLP (Firm ID: 185), New York, New York.
• ·Litigation details: U.S. Bank involved in RMBS trustee lawsuits and NCMSLT Action (C.A. No. 2018-0167-JRS, Del. Ch.), stayed and consolidated as of January 21, 2020.

30-03-2026

NYSEG Storm Funding, LLC, a wholly-owned bankruptcy-remote subsidiary of New York State Electric & Gas Corporation (itself a subsidiary of Avangrid, Inc.), filed its Form 10-K for the fiscal year ended December 31, 2025, with most content omitted per General Instruction J for asset-backed issuers. The filing confirms no material instances of noncompliance with servicing criteria by servicer New York State Electric & Gas Corporation or trustee U.S. Bank National Association. It discloses ongoing litigations against the trustee in RMBS and student loan trusts (with liability denied) and lists managers including Michael Panichi as President and Treasurer.

• ·Managers and officers listed as of March 27, 2026.
• ·Key agreements dated February 11, 2025: Indenture, Series Supplement, Recovery Property Servicing Agreement, Recovery Property Purchase and Sale Agreement, Administrative Agreement.
• ·Audited by KPMG, LLP (Firm ID: 185).
• ·Ongoing RMBS trustee litigations and NCMSLT Action (Del. Ch. C.A. No. 2018-0167-JRS) against U.S. Bank disclosed, with motions to dismiss/stay and consolidation orders noted; U.S. Bank denies liability.

30-03-2026

Carlyle Private Equity Partners Fund, L.P. (CPEP) reported total net assets of $46,182 and total assets of $59,046 as of December 31, 2025, for the period from inception on February 11, 2025, driven by $46,997 in proceeds from unit issuances. Investments at fair value totaled $44,900 (cost basis $41,722), representing 97.22% of net assets, with cash and cash equivalents at $11,176; however, there was a net decrease in net assets resulting from operations of $(740). Net cash used in operating activities was $(35,820), offset by strong financing inflows.

• ·Cost of investments purchased: $42,076; Proceeds from sales and repayments: $408
• ·Net realized gain on investments: $(55); Net change in unrealized appreciation on investments: $(3,177)
• ·Equity securities purchases: $33,823; Net change in unrealized appreciation on equity securities still held: $2,139
• ·Level III valuation: Discount rate weighted average 12.19% (range 8.20%-16.78%), Terminal growth rate 4.28% (2.00%-11.00%)
• ·Total investments cost breakdown: $29,034 Americas, $9,095 Europe, $3,478 Australia, $7,850 Japan, $3,098 Other Asia

30-03-2026

Vine Hill Capital Investment Corp. II (VHCP), a SPAC, filed its 10-K annual report on March 30, 2026, including audited financial statements for the period from inception on August 18, 2025, to December 31, 2025. The filing outlines strategies for transforming target businesses post-business combination to accelerate revenue growth and improve margins, while highlighting risks such as substantial debt service reducing cash available for dividends and operations, limitations on borrowing, and potential change of control from share issuances exceeding 60% of equity proceeds.

• ·Financial statements cover period from August 18, 2025 (inception) to December 31, 2025
• ·Includes Balance Sheet as of December 31, 2025; Statement of Operations; Statement of Changes in Shareholders’ Deficit; Statement of Cash Flows
• ·Risk of change of control if substantial ordinary shares issued

30-03-2026

CISO Global serves more than 437 clients across diverse sectors, with penetration of only approximately 20% for multiple services, positioning the company for revenue growth through cross-selling and upselling. However, it incurred significant operating losses during the years ended December 31, 2025 and 2024, has limited cash flow, and faces substantial doubt about its ability to continue as a going concern, with the auditor's opinion including an explanatory paragraph on this matter. The filing highlights strategic strengths like proprietary software and partnerships alongside extensive risk factors including talent shortages, long sales cycles, and competitive pressures.

• ·Dependence on a significant customer for a material portion of revenue and accounts receivable.
• ·Expectation not to pay cash dividends in the foreseeable future.
• ·Industry shortage of qualified compliance and cybersecurity professionals.
• ·Long and unpredictable sales cycles.
• ·Auditor’s opinion on financial statements for year ended December 31, 2025, includes going concern explanatory paragraph.

30-03-2026

Hyperion DeFi, Inc. reported revenue of $813,455 for FY 2025, up significantly from $57,336 in FY 2024, with gross profit turning positive at $510,165 from a $3,869,892 loss; net loss narrowed to $45,314,435 from $49,818,433. However, the company recorded massive impairments and unrealized losses on digital assets totaling over $36 million, alongside elevated SG&A expenses of $17,175,698 (up from $14,333,114), while R&D expenses dropped sharply to $1,910,430 from $14,462,722. Liquidity improved markedly with cash rising to $6,443,467 from $2,121,463 and working capital turning positive at $4,544,796 from a $13,279,008 deficit.

• ·Notes Payable (Gross) decreased to $8,339,366 as of Dec 31, 2025 from $10,740,402 as of Dec 31, 2024.
• ·Total Stockholders’ Equity turned positive at $41,060,507 as of Dec 31, 2025 from a deficit of $(13,095,952) as of Dec 31, 2024.
• ·Net Loss per Share improved to $(9.40) from $(59.81), with weighted average shares outstanding at 5,000,331 vs 832,997.